DESIPRAMINE 100 MG
DESIPRAMINE HYDROCHLORIDE : 100 MG · DIN 02216280 · AA PHARMA INC
Health Canada status: MARKETED
What is DESIPRAMINE?
DESIPRAMINE 100 MG contains DESIPRAMINE HYDROCHLORIDE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02216280, held by AA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 16-Dec-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DESIPRAMINE used for?
DESIPRAMINE (desipramine hydrochloride) is indicated for the treatment of endogenous depressive illness, including the depressed phase of manic depressive illness, involutional melancholia and psychotic depression. It may also be indicated in the management of depression of a non-psychotic degree such as in selected cases of depressive neurosis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02216280 |
|---|---|
| Brand name | DESIPRAMINE |
| Generic / active ingredient | DESIPRAMINE HYDROCHLORIDE : 100 MG |
| Manufacturer | AA PHARMA INC |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AA01 DESIPRAMINE |
| AHFS class | 28:16.04.28 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 16-Dec-2022 |
| Original market date | 1996-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02216280 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2216280 |
| Brand name | DESIPRAMINE |
| Active ingredient / INN | DESIPRAMINE HYDROCHLORIDE : 100 MG |
| ATC code | N06AA01 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N06 |
| AHFS class | 28:16.04.28 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | AA PHARMA INC |
How is it stored and handled?
null
How is it supplied?
10 mg - bottles of 100 tablets. 25 mg - bottles of 100 tablets. 50 mg - bottles of 100 tablets. 75 mg - bottles of 100 tablets. 100 mg - bottles of 100 tablets.
Which pack is which?
| Strength on the label | 100 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Packaging as described in the monograph | 10 mg - bottles of 100 tablets. 25 mg - bottles of 100 tablets. 50 mg - bottles of 100 tablets. 75 mg - bottles of 100 tablets. 100 mg - bottles of 100 tablets. |
| Storage | null |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code N06AA01 DESIPRAMINE. 5 of 49 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| DESIPRAMINE | 10 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02216248 |
| DESIPRAMINE | 25 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02216256 |
| DESIPRAMINE | 50 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02216264 |
| DESIPRAMINE | 75 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02216272 |
| DESIPRAMINE | 10 MG | TABLET | APOTEX INC | APPROVED | DIN 02211939 |
| DESIPRAMINE | 100 MG | TABLET | APOTEX INC | APPROVED | DIN 02211971 |
| DESIPRAMINE | 25 MG | TABLET | APOTEX INC | APPROVED | DIN 02211947 |
| DESIPRAMINE | 50 MG | TABLET | APOTEX INC | APPROVED | DIN 02211955 |
| DESIPRAMINE | 75 MG | TABLET | APOTEX INC | APPROVED | DIN 02211963 |
| DESIPRAMINE-10 - TAB 10MG | 10 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02222981 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.